SPANSIV Trademark

Trademark Overview


On Friday, March 16, 2012, a trademark application was filed for SPANSIV with the United States Patent and Trademark Office. The USPTO has given the SPANSIV trademark a serial number of 85571350. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 14, 2013. This trademark is owned by Glaxo Group Limited. The SPANSIV trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the tre...
spansiv

General Information


Serial Number85571350
Word MarkSPANSIV
Filing DateFriday, March 16, 2012
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 14, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 17, 2012

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording SPANSIV has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, March 26, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events


Event DateEvent Description
Tuesday, October 15, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, October 14, 2013ABANDONMENT - NO USE STATEMENT FILED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, February 19, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 15, 2013EXTENSION 1 GRANTED
Friday, February 15, 2013EXTENSION 1 FILED
Friday, February 15, 2013TEAS EXTENSION RECEIVED
Tuesday, September 11, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 17, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 17, 2012PUBLISHED FOR OPPOSITION
Wednesday, June 27, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 11, 2012ELECTRONIC RECORD REVIEW COMPLETE
Friday, June 8, 2012ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Tuesday, June 5, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 5, 2012ASSIGNED TO EXAMINER
Monday, March 26, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, March 20, 2012NEW APPLICATION ENTERED IN TRAM